Publication | Closed Access

Bupleurum chinense extract ameliorates an OVA-induced murine allergic asthma through the reduction of the Th2 and Th17 cytokines production by inactivation of NFκB pathway

InflammationAsthmaCytokineAllergyNfκb PathwayTh17 Cytokines ProductionAllergy MedicineMedicineImmunologyBupleurum Chinense ExtractAllergenImmunotherapyPharmacology